Research has shown that patients with blood cancers are less likely to enroll in hospice care than patients with solid cancers, and the findings from a national survey suggest that concerns about the adequacy of hospice may prevent blood cancer specialists from referring their patients. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to potential means of improving end-of-life care for patients with blood cancers such as leukemia and lymphoma.
Not only are these patients less likely to receive hospice care, but when they do enroll in hospice, they are also likely to spend less time under hospice care compared with other patients. Little is known about factors that account for these findings.
Because blood cancer patients' decision to enroll in hospice is typically preceded by referrals from their oncologists, Oreofe Odejide, MD, of the Dana-Farber Cancer Institute and her colleagues examined hematologic oncologists' perspectives regarding hospice.
The team conducted a survey of a national sample of hematologic oncologists listed in the publicly available clinical directory of the American Society of Hematology. More than 57 percent of physicians who were contacted provided responses, for a total of 349 respondents. The survey asked about views regarding the helpfulness and adequacy of home hospice services for patients with blood cancers, as well as factors that would impact oncologists' likelihood of referring patients to hospice.
More than 68 percent of hematologic oncologists strongly agreed that hospice care is "helpful" for patients with blood cancers. Despite high levels of agreement about the utility of hospice in general, 46 percent felt that home hospice is "inadequate" for the needs of patients with blood cancers. However, most of the respondents who believed home hospice is inadequate reported they would be more likely to refer patients if red blood cell transfusions were readily available.
"Our findings are important as they shed light on factors that are potential barriers to hospice referrals," said Dr. Odejide. "These findings can be employed to develop targeted interventions to address hospice underuse for patients with blood cancers."
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact:
Full Citation: "Why are Patients with Blood Cancers More Likely to Die without Hospice? Oreofe Odejide, Angel M. Cronin, Craig C. Earle, James A. Tulsky, and Gregory A. Abel. CANCER; Published Online: May 22, 2017 (DOI: 10.1002/cncr.30735).
URL Upon Publication: http://doi.
Author Contact: John W. Noble, of the Dana-Farber Cancer Institute's Department of Communications at email@example.com or +1 (617) 632-5784.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.
Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.